The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective cohort study using the UK Biobank.
Theresa J HydesOliver J KennedyRyan BuchananDaniel J CuthbertsonJulie ParkesSimon D S FraserPaul RoderickPublished in: BMC medicine (2023)
In people with CKD, NAFLD is associated with an increased risk of CVE, and the NAFLD fibrosis score is associated with an elevated risk of CVE and worse survival.